He had a happy childhood without any major crises, has a great, 50-year marriage, and now has 3 grandchildren.
Integrative Approach
The integrative approach necessitates communication between the allopathic and naturopathic practitioners for its success. Initially we would evaluate the conventional regimen, which in this case is gemcitabine on day 1 and day 8 with capecitabine given orally days 1 to 14. This means that effective and responsible co-management techniques would attend to the following regarding conventional treatments: (a) reduction of side effects; (b) support of their antineoplastic effects; and (c) noninterference of their intended effects. Furthermore, because this is a 21-day protocol, there is a 1-week gap where no chemotherapy is being administered, although there may be a washout period for the chemotherapy.
The Theraguide 5-FU test looks at genetics regarding the metabolic kinetics of 5-FU. Capecitabine is considered a pro-drug that becomes an active 5-FU-like substance in the target cell. However, if a patient lacks the activating enzyme (thymidylate synthase) or the by-product-degradation enzyme (dihydropyrimidine dehydrogenase), side effects can occur. Oftentimes such side effects are debilitating and require dose reductions or complete withdrawal of the drug. There was no mention of such testing being done. Nonetheless, common side effects from capecitabine may include palmar-plantar erythrodysesthesia (PPE), diarrhea, micronutrient depletion, and fatigue.
Gemcitabine provides subjective response (pain control, performance status, weight gain) even in absence of objective tumor response. Median survival for patients with metastatic disease receiving gemcitabine is 6 months, granting perhaps up to 2 months of additional expected survival. The primary impact of gemcitabine is on the quality of life by way of tumor control. Gemcitabine does not have a significant side-effect profile, but it may cause anemia, nausea, and fatigue.
A naturopathic co-management approach for this patient would be somewhat minimal given the fact that the patient reported minimal adverse effects. The abdominal pain that he described is most likely secondary to tumor impingement on the duodenum or liver capsule, or could be pain from secondarily affected digestive tract ulceration. In any case, given the significant adverse toxicity profile for capecitabine in particular, supplementation with several different agents could be considered. If the patient experienced nausea/vomiting, several botanicals can be helpful in alleviating the nausea, including Zingiber officinalis (ginger), Glycyrrhiza glabra (licorice), inhalation of the essential oil of Mentha piperita (peppermint), and infusion of Achillea millefolium (yarrow). If the patient experienced diarrhea, he could be a candidate for probiotics, 2 Ulmus fulva (slippery elm), and/or digestive enzymes. Additionally, L-glutamine may be indicated for digestive toxicity, as it is utilized in large quantities by enterocytes and thus facilitates intestinal repair. 3 Both weight loss and fatigue can be common adverse toxicities of chemotherapy and of pancreatic cancer. Weight loss is reported in this case and is explained as a consequence of planned dietary changes. This should be monitored very closely, as cachexia is almost universally present in patients with advanced pancreatic cancer. A prudent preventative strategy would include the use of adaptogenic herbs, 4 which have the ability to normalize the hypothalamic-pituitaryadrenal (HPA) axis. In the course of doing so, cortisolinduced TNF-α and other inflammatory cytokines can be regulated. This may be particularly relevant in this case given the patient's generalized anxiety (often a symptom of cortisolemia and altered HPA function). Additionally, should cachexia begin, daily intake of the supplement Avé (fermented wheat germ extract) may be useful, as this supplement has been shown to reduce cytokine-induced toxicities from chemotherapy. Furthermore, one author (DR) has significant clinical experience with and has also reported on the extract of young Rye grass (Secale cerale; Oralmat Drops Solution) 5 and its ability to aid reversal of the weight loss process. Intravenous vitamin C therapy may stabilize weight. Although this patient does not report experiencing hand-foot syndrome (PPE), because this is such a common toxicity from 5-FU, and a toxicity that can develop over subsequent cycles, proactive prevention is indicated. Vitamin B6 (pyridoxine), taken as 150 mg to 600 mg daily, is specifically indicated for prevention and treatment of fluorouracil-caused PPE. 6, 7 Should this patient have been on erlotinib, he most likely would have sustained similar side effects but to a greater degree. Additionally, the typical TKI skin rash may have ensued causing the patient to be in misery. Erlotinib is a known pharmacological inhibitor of the epidermal growth factor receptor (EGFR) and, in functioning as such, can reduce cancer cell mitosis, survival, and migration, and reduce angiogenic signaling as well as increase apoptotic death. EGFR blockade is a pragmatic approach to this patient, and several nutritional agents can act similarly, such as melatonin.
Molecular Approach
Melatonin has gained wide acceptance as an antineoplastic agent. Moreover, melatonin also has hormonal, immunological, and specific antioxidant effects as well. However, it does have a curious anticancer-cell effect in that it appears to exert direct and indirect inhibition of EGFR. Melatonin up-regulates the production of interleukin (IL)-2 and IL-12 by CD4 cells, which increase Th1directed tumor lysis. The indirect tumoricidal effect is achieved by reducing omega-6 fatty acid uptake by the malignant cell. Linoleic acid, aparent compound, enters the cancer cell and is quickly metabolized into 13-hydroxyoctadecadienoic acid, which then, through a series of metabolic steps, can stimulate the EGFR. Melatonin appears to stimulate an inhibitory G protein coupled receptor which then blocks linoleic acid uptake in the first place. As discussed subsequently, blockade of EGFR will result in reduction of the stimulation of the NFκB, nuclear factor kappa B.
In pancreatic adenocarcinoma, the EGFR pathway of signal transduction is typically overexpressed. One of the main signaling agents in this pathway is k-ras, which translates EGFR activity into MAP-kinase signaling and then to cellular mitosis. K-ras is mutated in the majority of invasive pancreatic cancers, 8 and the mutation up-regulates its activity. Although most k-ras mutations arise as the result of tobacco exposure, this patient is a nonsmoker. However, given this patient's family history inclusive of several cancers, he may have an inherited k-ras genetic mutation. Mutated k-ras can be identified in bile or pancreatic ductal secretions and can also be identified in genetic polymerase chain reaction testing. Agents that have the potential to down-regulate k-ras should be considered. Lovastatin inhibits HMG-CoA reductase, thus interfering with K-ras signaling. D-limonene prevents localization of K-ras proteins on cell membrane, thus interrupting signal transduction. 9 NFκB is a universal transcription factor involved in cellular responses to stressors and is an important molecular advantage for cancer cells. Upon activation, it is translocated to the nucleus, where it induces the expression of more than 200 genes that have been shown to suppress apoptosis and induce cellular transformation, proliferation, invasion, metastasis, chemo-resistance, radio-resistance, and inflammation. Many of the target genes that are activated are critical to the establishment of the early and late stages of aggressive cancers, and those required for metastasis and angiogenesis. 10 There are several components of this patient's history that indicate a role of inflammation in his malignancy he previously presented with pancreatitis; worked in the custodial department for decades, thus sustaining exposure to inflammatory cleaning agents; and suffered from sleep apnea, which is often the result of exposure to allergens with subsequent inflammatory swelling of pharyngeal tissue. Thus, blockade of NFκB seems to be a prudent goal. One of the most popular nutritional antiinflammatory agents, curcumin, provides for NFκB inhibition in several ways. These mechanisms have been well elucidated and are multifactorial. Curcumin induces apoptosis in pancreatic cancer cells 11 while simultaneously inducing hepatoprotective effects via decreasing proinflammatory cytokines (IL-1B, IL-6, TNF-α, IL-2). 12 Curcumin has been shown to reduce tumor growth in a mouse skin carcinogenesis model. 13 In fact, curcumin and other dietary agents such as resveratrol, genistein, and green tea catechins have anti-NFκB activity as well.
Green tea is particularly indicated in pancreatic cancer. Green tea catechins, such as epigallocatechin gallate (EGCG), inhibit NFκB. 14 EGCG also induces stress signals by initiating intracellular damage to the mitochondria, thereby increasing reactive oxygen speciesmediated JNK activation and apoptosis (in MIAPaCa-2 pancreatic carcinoma cells). 15 EGCG suppresses the invasive ability of pancreatic carcinoma cells PANC-1, MIAPaCa-2, and BxPC-3, thereby reducing their proliferative and invasive activities. 16 Black and green tea extracts, green tea polyphenols, and EGCG decrease the expression of the K-ras gene. 17 Green tea extracts should be standardized to at least 80% polyphenols with EGCG specified at 50%. Furthermore, gemcitabine is a known NFκB activator; inasmuch as it is an antineoplastic agent, it can therefore, molecularly speaking, promote the welfare of the tumor cells it seeks cytotoxicity toward. Genistein, a well-studied soy isoflavone, has demonstrated its utility as regarding pancreatic cancer in the following ways (mouse studies):
1. as an inhibitor of chemotherapy-induced NFκB activation; 18 2. as a synergist with gemcitabine; 19 3. reducing metastases; and 20 4. contributing to longer survival time. 20 Since NFκB is critical to the molecular "carry out" of the EGFR or other growth factor signaling, it would be also prudent to look "upstream" at ways to prevent its activation other than EGFR inhibition-hence, the notion of other growth factors or factors in general. Given that NFκB is regarded as a regulator of inflammation, it is noteworthy that IL-1 as well as IL-6 both have impacts on its transcription. NFκB actually marks the crossover between these 2 cytokines as a way for them to "meet in the middle." There are several routes to inflammation: cyclooxygenase-2, IL-1, IL-6, TNF-α, and others. Given the interrelatedness of these biochemical markers, NFκB inhibition is again a pragmatic approach to the treatment of pancreatic cancer.
Immunologic Approach
The importance of immunological control of pancreatic adenocarcinoma is undetermined. Nonetheless, influencing immunology as one aspect of a multipronged approach has theoretical merit. In this case, immunological control may be of particular relevance given the advanced age of the patient, age being a known factor for immune demise. Furthermore, this gentleman's history of custodial work may have exposed him to significant and diverse environmental toxicants with long-term immunological effects. Incidentally, melatonin increases IL-2-dependent cytotoxic immunity via increasing Th1 and decreasing Th2. 21 Furthermore, reversal or inference with IL-6 signaling and activity may help to reinstate an appropriate anti-tumor immune response.
Holistic and Lifestyle Approach
Naturopathic management of this patient must emphasize improvement in the quality of his life. The poor prognosis associated with this cancer along with the expected morbidity associated with this malignancy justifies prioritization of overall quality of life. The foundation of this approach lies in lifestyle fundamentals. The implementation of a whole foods, anti-inflammatory diet as has been recommended already is critical. The patient has maintained a robust exercise program combining aerobic and anaerobic exercises. This is essential for reduction of insulin resistance, perhaps indicated by his elevated IGF-1 level (although better assessed with c-peptide and postprandial glucose and insulin levels); incidentally, genistein has also demonstrated anti-IGF-1 activity. 22 Insulin resistance, with its concomitantly elevated insulin, creates a biochemical environment that favors tumor growth. Adequate sleep, which the patient experiences, is also a critical component to reduction of insulin resistance and inflammation. Reduction in both of these processes will improve his overall cytokine profile to disfavor inflammation and molecular activation of the aforementioned anabolic, tumor-promoting pathways, thus improving his overall quality of daily living.
Natural substances may also be supplemented with the intention of improving quality of life. Several key agents include melatonin, fish oils, and Avé. This patient appears to have sustained gastrointestinal ulceration. Melatonin counteracts the increase in the reactive oxygen speciesinduced lipid peroxidation and preserves, at least in part, the activity of key antioxidizing enzymes such as superoxide dismutase. This action indicates melatonin as an agent for prevention of gastric and pancreatic damage and in accelerating healing of gastric ulcers. 23 Fish oils are critical for overall quality-of-life issues. This patient has already been recommended fish oil capsules. Omega-3 fatty acid levels are reduced in pancreatic cancer. 24 Various mediators of catabolism in cachexia are modulated by administration of a fish oil-enriched nutritional supplement in pancreatic cancer patients. This may account for the reversal of weight loss in patients consuming this supplement. 25 Preliminary studies of a combination of fish oil as an anti-inflammatory agent with nutritional supplementation show promise in reversing weight loss with apparent gains in lean tissue and performance status in association with normalization of the metabolic environment in patients with advanced pancreatic cancer. 26 Fish oil will also help to reduce the IL-6, the role of which has already been discussed. Eicosapentaenoic acid exerts an antineoplastic effect on the pancreatic cancer cell line MIAPaCa-2, at least in part via cell cycle arrest and the induction of apoptosis. 27 Avé, fermented wheat germ extract, may also improve daily quality of living. Avé inhibits COX-1 and COX-2, thereby reducing inflammation-induced cachexia and tumor progression as well as many other molecular effects as well. 28 This patient appears to have responded well to his initial conventional treatment. The incorporation of a naturopathic approach would augment the overall antineoplastic intent of his treatment and thus potentially provide additional prolongation of his life. Additionally, a naturopathic approach would also enhance the quality of his daily living.
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